Role of Big Tech in Society
Debate between Bell Ribeiro-Addy and Jeremy Wright(1 month, 1 week ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Bell Ribeiro-Addy
That is why I was so pleased the right hon. Member called the debate. I hope he agrees that once a contractor has failed for one Department, it should not be given a contract for another Department. I hope the Minister will speak to that.
I hugely support my constituents’ call for the Government to use that February 2027 break clause with Palantir. I hope the Minister will tell us more about whether they intend to act on that. Some will say that Palantir’s expanding portfolio simply proves that it is the best company for the job. That may be true for some places—I doubt it—but it is not a reason to dismiss concerns. We should be worried about one company having this much dominance across so many pillars of our society, and particularly a foreign corporation that may not have the UK’s best interests at heart. I say that with confidence, because Palantir’s founder, Peter Thiel, has accused us of having Stockholm syndrome over our affection for the NHS and said that we need to
“rip the whole thing from the ground and start over”.
His broader political views are just as concerning, and I encourage Members to look into them.
The current CEO of Palantir UK is Oswald Mosley’s grandson. I do not wish to judge a man solely by his grandfather’s sins, but that gets harder when the views on display are not entirely dissimilar. Nor can we ignore Peter Mandelson’s role in arranging the Prime Minister’s undeclared 2025 visit to Palantir’s headquarters—a meeting where no minutes were taken and that raised transparency questions that are still unanswered.
The second concern is data. Palantir built its reputation as a surveillance and intelligence tool for the US military; it is not a healthcare company, but a data aggregation company with software designed to link datasets across systems. This is no longer a hypothetical risk: NHS England has confirmed that Palantir staff can access identifiable patient data on the federated data platform through a new admin role on the national data integration tenant. The British Medical Association, Medacs, the Good Law Project, Privacy International and Amnesty International have all warned that that data could become accessible to other departments, or to US authorities under the American Clarifying Lawful Overseas Use of Data Act 2018, regardless of what any contract says.
Some 50,000 patients have written to their NHS trust boards to urge them not to adopt the platform. I am not suggesting that every Palantir contract should be cancelled tomorrow, but we are sleepwalking into a dependency on this company that we will come to deeply regret.
Sir Jeremy Wright (in the Chair)
We have not been universally successful at keeping to four minutes. I ask everyone to now get closer to three minutes, because I need to begin Front-Bench contributions at 5.28 pm.